FailedDiscontinued

Zelenectide pevedotin (zele, formerly BT8009)

Solid tumor/s, Cancer, NECTIN4-amplified breast cancer

BCYCBicycle Therapeutics plc

Expected catalystTBA

Catalyst overview

Event details

Drug or asset: Zelenectide pevedotin (zele, formerly BT8009)
Development stage: Failed
Event type: Discontinued
Indication: Solid tumor/s, Cancer, NECTIN4-amplified breast cancer

Research summary

What is being tracked?

This catalyst tracks a Failed discontinued for Zelenectide pevedotin (zele, formerly BT8009) in Solid tumor/s, Cancer, NECTIN4-amplified breast cancer. The expected timing is based on the latest available company guidance and may change.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Source URL not provided

FailedDiscontinued

Zelenectide pevedotin (zele, formerly BT8009)

Solid tumor/s, Cancer, NECTIN4-amplified breast cancer

BCYCBicycle Therapeutics plc

Expected catalystTBA

Catalyst overview

Event details

Drug or asset: Zelenectide pevedotin (zele, formerly BT8009)
Development stage: Failed
Event type: Discontinued
Indication: Solid tumor/s, Cancer, NECTIN4-amplified breast cancer

Research summary

What is being tracked?

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Source URL not provided

Zelenectide pevedotin (zele, formerly BT8009)

Event details

What is being tracked?

Primary source

Related pipeline programs